Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Department of Pathology, Radboud University Medical Centre, Nijmegen, The Netherlands.
Abdom Radiol (NY). 2022 Oct;47(10):3375-3385. doi: 10.1007/s00261-022-03573-7. Epub 2022 Jul 7.
To investigate whether locoregional staging of colon cancer by experienced radiologists can be improved by training and feedback to minimize the risk of over-staging into the context of patient selection for neoadjuvant therapy and to identify potential pitfalls of CT staging by characterizing pathologic traits of tumors that remain challenging for radiologists.
Forty-five cases of stage I-III colon cancer were included in this retrospective study. Five experienced radiologists evaluated the CTs; 5 baseline scans followed by 4 sequential batches of 10 scans. All radiologists were trained after baseline scoring and 2 radiologists received feedback. The learning curve, diagnostic performance, reader confidence, and reading time were evaluated with pathologic staging as reference. Pathology reports and H&E slides of challenging cases were reviewed to identify potential pitfalls.
Diagnostic performance in distinguishing T1-2 vs. T3-4 improved significantly after training and with increasing number of reviewed cases. Inaccurate staging was more frequently related to under-staging rather than over-staging. Risk of over-staging was minimized to 7% in batch 3-4. N-staging remained unreliable with an overall accuracy of 61%. Pathologic review identified two tumor characteristics causing under-staging for T-stage in 5/7 cases: (1) very limited invasive part beyond the muscularis propria and (2) mucinous composition of the invading part.
The high accuracy and specificity of T-staging reached in our study indicate that sufficient training and practice of experienced radiologists can ensure high validity for CT staging in colon cancer to safely use neoadjuvant therapy without significant risk of over-treatment, while N-staging remained unreliable.
通过培训和反馈,研究有经验的放射科医生对结肠癌的局部区域分期是否可以得到改善,以尽量降低在选择新辅助治疗患者时过度分期的风险,并通过对肿瘤病理特征进行特征描述来确定 CT 分期的潜在陷阱,这些特征对放射科医生来说具有挑战性。
本回顾性研究纳入了 45 例 I-III 期结肠癌患者。5 名有经验的放射科医生评估了 CT 扫描结果;5 名医生在基线评分后,对 5 组共 10 个 CT 扫描进行了评估。所有放射科医生在基线评分后均接受了培训,其中 2 名放射科医生收到了反馈。以病理分期为参考,评估了学习曲线、诊断性能、读者信心和阅读时间。为了确定潜在的陷阱,对具有挑战性的病例的病理报告和 H&E 切片进行了回顾。
经过培训和评估更多病例后,区分 T1-2 与 T3-4 的诊断性能显著提高。不准确的分期更多地与分期不足有关,而不是过度分期。在第 3-4 批评估中,过度分期的风险最小化至 7%。N 分期的准确性仍然不可靠,总准确率为 61%。病理复查确定了导致 T 分期分期不足的两种肿瘤特征,在 5/7 例中:(1)侵犯部分超出肌层的范围非常有限;(2)侵犯部分的黏液组成。
本研究中 T 分期达到的高准确性和特异性表明,有经验的放射科医生进行充分的培训和实践可以确保 CT 分期在结肠癌中的高有效性,从而可以安全地使用新辅助治疗,而不会有过度治疗的显著风险,而 N 分期仍然不可靠。